These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15848955)

  • 41. Binary Antisense Oligonucleotide Agent for Cancer Marker-Dependent Degradation of Targeted RNA.
    Drozd VS; Eldeeb AA; Kolpashchikov DM; Nedorezova DD
    Nucleic Acid Ther; 2022 Oct; 32(5):412-420. PubMed ID: 35852843
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Determination of optimal sites of antisense oligonucleotide cleavage within TNFalpha mRNA.
    Lloyd BH; Giles RV; Spiller DG; Grzybowski J; Tidd DM; Sibson DR
    Nucleic Acids Res; 2001 Sep; 29(17):3664-73. PubMed ID: 11522838
    [TBL] [Abstract][Full Text] [Related]  

  • 43. RNase H1-Dependent Antisense Oligonucleotides Are Robustly Active in Directing RNA Cleavage in Both the Cytoplasm and the Nucleus.
    Liang XH; Sun H; Nichols JG; Crooke ST
    Mol Ther; 2017 Sep; 25(9):2075-2092. PubMed ID: 28663102
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Implication of RNA structure on antisense oligonucleotide hybridization kinetics.
    Lima WF; Monia BP; Ecker DJ; Freier SM
    Biochemistry; 1992 Dec; 31(48):12055-61. PubMed ID: 1280997
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of bacterial RNase P RNA as a drug target.
    Willkomm DK; Gruegelsiepe H; Goudinakis O; Kretschmer-Kazemi Far R; Bald R; Erdmann VA; Hartmann RK
    Chembiochem; 2003 Oct; 4(10):1041-8. PubMed ID: 14523922
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluating the specificity of antisense oligonucleotide conjugates. A DNA array analysis.
    Fisher AA; Ye D; Sergueev DS; Fisher MH; Shaw BR; Juliano RL
    J Biol Chem; 2002 Jun; 277(25):22980-4. PubMed ID: 11948195
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 2'-Modified oligonucleotides for antisense therapeutics.
    Prakash TP; Bhat B
    Curr Top Med Chem; 2007; 7(7):641-9. PubMed ID: 17430205
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oligonucleotide-poly-L-ornithine conjugates: binding to complementary DNA and RNA.
    Zhu T; Wei Z; Tung CH; Dickerhof WA; Breslauer KJ; Georgopoulos DE; Leibowitz MJ; Stein S
    Antisense Res Dev; 1993; 3(3):265-75. PubMed ID: 8286927
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hybridization of antisense reagents to RNA.
    Sohail M; Southern EM
    Curr Opin Mol Ther; 2000 Jun; 2(3):264-71. PubMed ID: 11249620
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pathways of degradation and mechanism of action of antisense oligonucleotides in Xenopus laevis embryos.
    Dagle JM; Weeks DL; Walder JA
    Antisense Res Dev; 1991; 1(1):11-20. PubMed ID: 1668307
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Properties of nicked and circular dumbbell RNA/DNA chimeric oligonucleotides containing antisense phosphodiester oligodeoxynucleotides.
    Yamakawa H; Abe T; Saito T; Takai K; Yamamoto N; Takaku H
    Bioorg Med Chem; 1998 Jul; 6(7):1025-32. PubMed ID: 9730239
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antisense oligonucleotide containing an internal, non-nucleotide-based linker promote site-specific cleavage of RNA.
    Reynolds MA; Beck TA; Say PB; Schwartz DA; Dwyer BP; Daily WJ; Vaghefi MM; Metzler MD; Klem RE; Arnold LJ
    Nucleic Acids Res; 1996 Feb; 24(4):760-65. PubMed ID: 8604321
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of RNA-protein complexes by oligonucleotide-targeted RNase H digestion.
    Günzl A; Palfi Z; Bindereif A
    Methods; 2002 Feb; 26(2):162-9. PubMed ID: 12054893
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The rates of the major steps in the molecular mechanism of RNase H1-dependent antisense oligonucleotide induced degradation of RNA.
    Vickers TA; Crooke ST
    Nucleic Acids Res; 2015 Oct; 43(18):8955-63. PubMed ID: 26384424
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A novel integrated strategy (full length gene targeting) for mRNA accessible site tagging combined with microarray hybridization/RNase H cleavage to screen effective antisense oligonucleotides.
    Sun Y; Duan M; Lin R; Wang D; Li C; Bo X; Wang S
    Mol Vis; 2006 Nov; 12():1364-71. PubMed ID: 17149362
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A ribonuclease H-oligo DNA conjugate that specifically cleaves hepatitis B viral messenger RNA.
    Walton CM; Wu CH; Wu GY
    Bioconjug Chem; 2001; 12(5):770-5. PubMed ID: 11562195
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thermodynamic and kinetic characterization of antisense oligodeoxynucleotide binding to a structured mRNA.
    Walton SP; Stephanopoulos GN; Yarmush ML; Roth CM
    Biophys J; 2002 Jan; 82(1 Pt 1):366-77. PubMed ID: 11751323
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology.
    Gao WY; Han FS; Storm C; Egan W; Cheng YC
    Mol Pharmacol; 1992 Feb; 41(2):223-9. PubMed ID: 1371582
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design of antisense oligonucleotides stabilized by locked nucleic acids.
    Kurreck J; Wyszko E; Gillen C; Erdmann VA
    Nucleic Acids Res; 2002 May; 30(9):1911-8. PubMed ID: 11972327
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of multiple-turnover capability of locked nucleic acid antisense oligonucleotides in cell-free RNase H-mediated antisense reaction and in mice.
    Yamamoto T; Fujii N; Yasuhara H; Wada S; Wada F; Shigesada N; Harada-Shiba M; Obika S
    Nucleic Acid Ther; 2014 Aug; 24(4):283-90. PubMed ID: 24758560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.